Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Blocks in Robotic Gynecologic Oncology Surgery
NCT01444924Phase 2
Key facts
- Status
- Completed
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Countries
- 1
- Sponsor
- University of Wisconsin–Madison
- Modality
- Small Molecules
- Drugs
- bupivacaine
- Conditions
- postoperative pain
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Bupivicaine with Placebo (2 arms). Primary endpoint: 24 Hour Post Operative Opioid Consumption, Converted to Intravenous Morphine Equivalents. Started Sep 2011; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Bupivicaine
TAP block with bupivacaine/epinephrine
Placebo
TAP block with saline placebo
03
Endpoints
Primary
24 Hour Post Operative Opioid Consumption, Converted to Intravenous Morphine Equivalents
Secondary
Pain Scores
Beyond the preview
Go deeper on NCT01444924.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444924.